Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank91
5Y CAGR+33.5%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
+33.5%/yr
Long-term compound
Percentile
P91
Near historical high
vs 5Y Ago
4.2x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 11.15% |
| Q2 2025 | -4.84% |
| Q1 2025 | 2.84% |
| Q4 2024 | 7.61% |
| Q3 2024 | -11.59% |
| Q2 2024 | -11.43% |
| Q1 2024 | -15.03% |
| Q4 2023 | -12.09% |
| Q3 2023 | 50.68% |
| Q2 2023 | -11.86% |
| Q1 2023 | -36.63% |
| Q4 2022 | -27.84% |
| Q3 2022 | -28.85% |
| Q2 2022 | -24.31% |
| Q1 2022 | -21.58% |
| Q4 2021 | -12.42% |
| Q3 2021 | -10.55% |
| Q2 2021 | -24.24% |
| Q1 2021 | -13.36% |
| Q4 2020 | -12.19% |
| Q3 2020 | 2.63% |
| Q2 2020 | -8.56% |
| Q1 2020 | -24.91% |
| Q4 2019 | -11.08% |
| Q3 2019 | -10.95% |
| Q2 2019 | 2309.73% |
| Q1 2019 | 32.05% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |